Literature DB >> 32534039

Use Chou's 5-steps rule to evaluate protective efficacy induced by antigenic proteins of Mycobacterium tuberculosis encapsulated in chitosan nanoparticles.

Ramendra Pati Pandey1, Santosh Kumar2, Saheem Ahmad3, Arpana Vibhuti4, V Samuel Raj5, Anita Kamra Verma6, Pawan Sharma2, Elcio Leal7.   

Abstract

The study focuses on whether antigenic proteins encapsulated in biopolymeric nanoparticles can augment protective efficacy. Chitosan nanoparticles (ChN) were prepared by ionic gelation method and Culture Filtrate Proteins (CFP) - CFP-10 and CFP-21 of Mycobacterium tuberculosis (Mtb) were encapsulated in ChN. The binding efficiency of nanoparticles with CFP-10 and CFP-21 proteins was confirmed by UV-Spectrophotometer. The efficacy of nanoparticles-encapsulated antigenic proteins administered intraperitoneal against Mtb aerosol infection was evaluated in Balb/c mice. Protection study was done by bacterial counts [CFU]. CFP-10 and CFP-21 proteins primed cells demonstrated a Th1 bias T cell response in an ex vivo assay. ChN-CFP10 and ChN-CFP21 nanoparticles have both protective and therapeutic potential against Mtb. In the group of mice immunized with CHN-CFP-10 the number of colonies reduced significantly from day 15 to day 60. ChN-CFP-21 showed maximum protection in ChN-CFP-21 immunized mice. ChN-CFP-10 and ChN-CFP-21 clearly showed enhanced protection against Mtb.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CFU; Chitosan nanoparticles; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32534039     DOI: 10.1016/j.lfs.2020.117961

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Chitosan Microparticles Loaded with New Non-Cytotoxic Isoniazid Derivatives for the Treatment of Tuberculosis: In Vitro and In Vivo Studies.

Authors:  Ionut Dragostin; Oana-Maria Dragostin; Andreea Teodora Iacob; Maria Dragan; Carmen Lidia Chitescu; Luminita Confederat; Alexandra-Simona Zamfir; Rodica Tatia; Catalina Daniela Stan; Carmen Lacramioara Zamfir
Journal:  Polymers (Basel)       Date:  2022-06-07       Impact factor: 4.967

2.  β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells.

Authors:  Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Peter J Cabot; Nazrul Islam; Emad L Izake
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

3.  Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis.

Authors:  Yan Lin; Yu Dong; Yanfeng Gao; Ranran Shi; Yubing Li; Xiuman Zhou; Wenwen Liu; Guodong Li; Yuanming Qi; Yahong Wu
Journal:  J Immunol Res       Date:  2021-01-05       Impact factor: 4.818

4.  Application of antigenic biomarkers for Mycobacterium tuberculosis.

Authors:  Elba Rodríguez-Hernández; Laura Itzel Quintas-Granados; Susana Flores-Villalva; Jorge Germinal Cantó-Alarcón; Feliciano Milián-Suazo
Journal:  J Zhejiang Univ Sci B       Date:  2020 Nov.       Impact factor: 3.066

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.